Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

NCT02944357 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Infiltrating Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma
Stage III Bladder Urothelial Carcinoma
Stage IV Bladder Urothelial Carcinoma

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine Hydrochloride
PROCEDURE: Radical Cystectomy
BIOLOGICAL: Tumor Cell-Derived Vaccine Therapy

Sponsor

Mayo Clinic

Collaborators

[object Object]